NIFTY CHART UPDATED 05/07/2016 EOD...
LEVEL TO WATCH ON CHART...
HAPPY TRADING !!!
Analysis given with mandatory disclosure given on site on 03/12/2014.
Please read it before taking any trading decisions...
Glenmark Pharmaceuticals Ltd (GLENMARK) – Q1 FY2026-27 Results Analysis
-
Executive Summary: The Headline Strong recovery quarter: Consolidated
Revenue +23% YoY to ₹4,018 Cr. PAT surged to ₹483 Cr (vs ₹47 Cr YoY —
multi-fold ju...
22 hours ago
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.